Top Industry News
- TGA - Australian regulatory guidelines for biologicals (ARGB)
- DMA - All marketing authorisation letters are now sent electronically to Danish companies
- EMA - Medicinal products for human use Safety, environment and information: Excipients in the labelling and package leaflet of medicinal products for human use
- Regulatory Intelligence: 2017 FDA Review and Trends to Watch
- Health Canada Clarifies Risk Classification Process in Drug Manufacturing Site Inspections
- Ethiopian Pharmaceutical Industry Growth and Development of its Regulatory Systems
- FDA - Standardization of Data and Documentation Practices for Product Tracing
- FDA - Definitions of Suspect Product and Illegitimate Product for Verification Obligations Under the Drug Supply Chain Security Act
- FDA - E6(R2) Good Clinical Practice: Integrated Addendum to ICH E6(R1)
- FDA - E18 Genomic Sampling and Management of Genomic Data Guidance